Association between serological, hematological and biochemical status and cardiac involvement in rheumatic connective tissue diseases
References
- Mulhearn B, Tansley SL, McHugh NJ. Autoantibodies in connective tissue disease. Best Pract Res Clin Rheumatol. 2020;34(1):101462.
- Podlesnikar T, Lapinskas T. Cardiac Involvement in Connective Tissue Disorders: Terra Incognita. JACC Case Rep. 2019; 1(2):243-245.
- Pan SY, Tian HM, Zhu Y, et al. Cardiac damage in autoimmune diseases: Target organ involvement that cannot be ignored. Front Immunol. 2022; 13:1056400.
- Bordy R, Totoson P, Prati C, Marie C, Wendling D, Demougeot C. Microvascular endothelial dysfunction in rheumatoid arthritis. Nat Rev Rheumatol. 2018; 14(7):404-420.
- Buleu F, Sirbu E, Caraba A, Dragan S. Heart Involvement in Inflammatory Rheumatic Diseases: A Systematic Literature Review. Medicina (Kaunas). 2019; 55(6):249.
- van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013; 72(11):1747-55.
- Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019; 71(9):1400-1412.
- Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010; 69(9):1580-8. Erratum in: Ann Rheum Dis. 2010; 69(10):1892.
- Lee KS, Kronbichler A, Eisenhut M, Lee KH, Shin JI. Cardiovascular involvement in systemic rheumatic diseases: An integrated view for the treating physicians. Autoimmun Rev. 2018; 17(3):201-214.
- Lee SH, Tag HS, Kim GT, et al. Effect of rheumatoid factor on vascular stiffness in general population without joint symptoms. Kosin Med J. 2017; 32(1):25–35.
- Bedeković D, Bošnjak I, Šarić S, Kirner D, Novak S. Role of Inflammatory Cytokines in Rheumatoid Arthritis and Development of Atherosclerosis: A Review. Medicina (Kaunas). 2023; 59(9):1550.
- Fazeli MS, Khaychuk V, Wittstock K, et al. Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors, Autoantibodies, and the Effect of Antirheumatic Therapies. Clin Med Insights Arthritis Musculoskelet Disord. 2021; 14:11795441211028751.
- Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012; 71(9):1524-9.
- Carbonell-Bobadilla N, Soto-Fajardo C, Amezcua-Guerra LM, et al. Patients with seronegative rheumatoid arthritis have a different phenotype than seropositive patients: A clinical and ultrasound study. Front Med (Lausanne). 2022;9:978351.
- Naeem A, Khan MH, Khan O, et al. Cardiac disease in systemic sclerosis: a narrative review. Arch Med Sci Atheroscler Dis. 2025; 10:e121-e138.
- Radić M, Bečić T, Šimac P, et al. Predictive Value of Classical and Emerging Autoantibodies for Cardiac Dysfunction in Systemic Sclerosis: Systematic Review. Journal of Clinical Medicine. 2025; 14(18):6383.
- Zagouras AA, Tang WHW. Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases. Rheum Dis Clin North Am. 2023; 49(1):45-66.
- Crowson CS, Therneau TM, Davis JM 3rd, Roger VL, Matteson EL, Gabriel SE. Brief report: accelerated aging influences cardiovascular disease risk in rheumatoid arthritis. Arthritis Rheum. 2013; 65(10):2562-6.
- Akgöl G, Gülkesen A, Uslu EY, et al. Can myocardial dysfunction be detected in patients with rheumatoid arthritis with no cardiac symptoms? Eur Rev Med Pharmacol Sci. 2023;27(10):4399-4405.
- Vázquez-Del Mercado M, Gomez-Bañuelos E, Chavarria-Avila E, et al. Disease duration of rheumatoid arthritis is a predictor of vascular stiffness: a cross-sectional study in patients without known cardiovascular comorbidities: A STROBE-compliant article. Medicine (Baltimore). 2017; 96(33):e7862.
- Przepiera-Bedzak H, Brzosko I, Peregud-Pogorzelska M, Wódecki M, Brzosko M. Zmiany w układzie sercowo-naczyniowym w przebiegu seronegatywnych spondyloartropatii zapalnych [Cardiovascular manifestations of seronegative inflammatory spondyloarthropathies]. Ann Acad Med Stetin. 2010; 56 Suppl 1:62-5. Polish.
- Liang KP, Myasoedova E, Crowson CS, et al. Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis. 2010; 69(9):1665-70.
- Qian Y, Zhang B, Nian F. The association between rheumatoid arthritis and left ventricular diastolic dysfunction: pathogenesis, predictors and managements. Clin Exp Rheumatol. 2025; 43(1):135-144.
- Vemulapalli S, Cohen L, Hsu V. Prevalence and risk factors for left ventricular diastolic dysfunction in a scleroderma cohort. Scand J Rheumatol. 2017; 46(4):281-287.
- Aronow W. S. Cardiac Arrhythmias-Mechanisms, Pathophysiology, and Treatment. Rijeka, Croatia: InTech; 2014.
- Biancucci M, Barbiero R, Pennella B, et al. Hypoalbuminaemia and heart failure: A practical review of current evidence. Eur J Heart Fail. 2025; 27(2):293-306.
- Luo M, Anderson ME. Mechanisms of altered Ca²⁺ handling in heart failure. Circ Res. 2013; 113(6):690-708.
- Tarjanyi Z, Szabo L, Mong N, et al. Subclinical myocardial changes in rheumatoid arthritis: cardiovascular magnetic resonance evidence of immuno-inflammatory remodeling. Front Cardiovasc Med. 2025; 12:1607018.
- Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005; 352(10):1011-23.
- Ibrahim A, Tseng J, Bharadwaj A, Nandagudi A. Spectrum of anaemia in rheumatic diseases and the involvement of rheumatologists in the management: a single centre study. Clin Med (Lond). 2025; 25(4 Suppl):100460.
- Xue L, Tao L, Sun H, et al. Association Between Blood PLT and RBC Related Indices and Disease Activity in Patients with Rheumatoid Arthritis. Int J Gen Med. 2022; 15:573-581.
- Mu H, Wang X, Zhao X, et al. Hematological parameters and major adverse cardiovascular events: a prospective study in a Chinese population involving 2,970 participants. Int J Med Sci. 2025; 22(8):1924-1935.
- Surma S, Banach M. Fibrinogen and Atherosclerotic Cardiovascular Diseases—Review of the Literature and Clinical Studies. International Journal of Molecular Sciences. 2022; 23(1):193.
- Pope JE, Choy EH. C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Semin Arthritis Rheum. 2021; 51(1):219-229.
- Agca R, Heslinga SC, Rollefstad S, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017; 76(1):17-28.
- Litao MK, Kamat D. Erythrocyte sedimentation rate and C-reactive protein: how best to use them in clinical practice. Pediatr Ann. 2014;43(10):417-20.
- Myasoedova E, Crowson CS, Kremers HM, et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis. 2011; 70(3):482-7.
- Alkhudair D. Beyond the joints: exploring electrolyte and renal complications in rheumatoid arthritis. Medical Research Archives. 2025; 13(6). Available from: Medical Research Archives website. Accessed January 30, 2026.
- Cheng X, Liu L, Tian Y, Lin Y. Serum lactate dehydrogenase as a prognostic marker for 90-day mortality in connective tissue disease patients receiving glucocorticoids and hospitalized with pneumonia: a cohort study. Sci Rep. 2025;15(1):16806.
- Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: Pathogenesis and Clinical Significance. JPEN J Parenter Enteral Nutr. 2019; 43(2):181-193.
Language: English
Page range: 105 - 112
Submitted on: Dec 18, 2025
Accepted on: Apr 6, 2026
Published on: Jul 3, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Enisa Hodžić, Alma Islamović, Nina Čamdžić, Jasna Salkić, Amina Zorlak-Čavčić, Dino Spasovski, Mevludin Mekić, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.